Last reviewed · How we verify
Plasma exchanges and intravenous immunoglobulins — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Plasma exchanges and intravenous immunoglobulins (Plasma exchanges and intravenous immunoglobulins) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Plasma exchanges and intravenous immunoglobulins TARGET | Plasma exchanges and intravenous immunoglobulins | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Plasma exchanges and intravenous immunoglobulins CI watch — RSS
- Plasma exchanges and intravenous immunoglobulins CI watch — Atom
- Plasma exchanges and intravenous immunoglobulins CI watch — JSON
- Plasma exchanges and intravenous immunoglobulins alone — RSS
Cite this brief
Drug Landscape (2026). Plasma exchanges and intravenous immunoglobulins — Competitive Intelligence Brief. https://druglandscape.com/ci/plasma-exchanges-and-intravenous-immunoglobulins. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab